Picture of Celyad Oncology SA logo

CYAD — Celyad Oncology SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Celyad Oncology Announces Intention To Terminate SEC Reporting Obligations

Feb 8 (Reuters) - Celyad Oncology SA  CYAD.BR :
    * CELYAD ONCOLOGY ANNOUNCES INTENTION TO TERMINATE SEC
REPORTING
OBLIGATIONS
    * CELYAD ONCOLOGY SA - WILL VOLUNTARILY FILE FORM 15F WITH
UNITED
STATES SEC TO TERMINATE ITS SEC REPORTING OBLIGATIONS
    * CELYAD ONCOLOGY SA - UPON FILING OF FORM 15F, COMPANY'S
SEC
REPORTING OBLIGATIONS WILL BE IMMEDIATELY SUSPENDED
    * CELYAD ONCOLOGY SA - WILL MAINTAIN LISTING OF ITS ORDINARY
SHARES ON EURONEXT BRUSSELS AND EURONEXT PARIS

Source text for Eikon:  ID:nGNX2MVC3p 
Further company coverage:  CYAD.BR 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Celyad Oncology SA

See all news